Loading... Please wait...
Create an account
Therapy Trends Updates
Therapy Area Reports
Alphabetical: A to Z
Alphabetical: Z to A
Orphan Drugs: Pricing and Market Access Strategies
Orphan drug market access and pricing: strategies for success When it comes to securing market access and drug pricing for orphan drugs, a one size approach won’t work. Driven by increasing competition and cost...
Orphan Drug Market Access: Payer Insights on the Present and Future (2016)
How to ensure positive payer engagement for orphan drug market access The explosion in orphan drug approvals and high prices are causing increasing concern to payers. When there were few orphan drugs for small patient...
The Future of Orphan Drugs
Orphan Drugs: Future opportunities and challenges The orphan drug sector is booming. Record product approvals, robust pipelines and regulatory incentives. But will the good times last? As the market matures...
Patient Engagement in Orphan Drugs
Why is the patient voice critical to orphan drug success? Patient input is critical to an orphan drug’s success, but how and when should you engage and what trends and drivers are shaping their involvement?...
Orphan Drug Commercial Models: Sustaining the rare disease business
Choosing the right commercial model for orphan drug success The societal and commercial ambitions of orphan drug developers determine which commercial model will best meet their aims. Profit, potential and patient...
Commercial Excellence in Rare Diseases and Orphan Drugs
Developing therapies for orphan diseases is attracting much industry interest with the promise of profits. But what are the specific R&D, regulatory, stakeholder and market access issues you need to understand and...
All Contents Copyright © 2017 Doctor's Guide Publishing Limited All Rights Reserved